Document is current
Any future updates will be listed below
-
Authors
Wang, Pingluan https://orcid.org/0000-0002-7817-7709
Ye, Chang https://orcid.org/0000-0003-0236-5671
Zhao, Michelle
Jiang, Bochen https://orcid.org/0000-0001-6686-8847
He, Chuan https://orcid.org/0000-0003-4319-7424
-
Funding
Funding for this research was provided by:
Foundation for the National Institutes of Health (HG008935)
Foundation for the National Institutes of Health (HG008935)
Foundation for the National Institutes of Health (HG008935)
Foundation for the National Institutes of Health (HG008935)
Foundation for the National Institutes of Health (HG008935)
- License Information
-
More Information
Article History
Received: 3 June 2024
Accepted: 11 March 2025
First Online: 17 April 2025
Competing interests
: C.H. is a scientific founder, a member of the scientific advisory board and equity holder of Aferna Bio and Ellis Bio, a scientific cofounder and equity holder of Accent Therapeutics, and a member of the scientific advisory board of Rona Therapeutics and Element Biosciences. The other authors declare no competing interests.
